ctrl K

EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.26

0.00 (0.00%)

At close: Apr 28, 2025, 3:07 PM

35.31

0.16%

After-hours: Apr 29, 2025, 04:00 PM EDT

EyeGate Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.79M	1.19M	3.78M	8M	7.81M	3.64M
Short-Term Investments	23M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	28.97K	102.07K	114.4K	76.71K	352.13K	100.31K
Receivables	n/a	90.97K	4.86K	18.44K	23.68K	53.83K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.91M	533.5K	542.74K	455.76K	629.59K	464.98K
Total Current Assets	29.71M	1.81M	4.32M	8.48M	8.46M	4.15M
Property-Plant & Equipment	62.4K	30.57K	16.85K	43.52K	55.75K	38.04K
Goodwill & Intangibles	6.69M	13.21M	5.66M	5.68M	5.44M	5.44M
Total Long-Term Assets	6.78M	13.35M	5.79M	5.8M	5.85M	5.58M
Total Assets	36.48M	15.16M	10.11M	14.28M	14.31M	9.73M
Account Payables	415.59K	434.76K	210.29K	63.65K	706.09K	1.41M
Deferred Revenue	n/a	n/a	n/a	2.69M	12.31M	4.22M
Short-Term Debt	23.36K	48.3K	83.93K	4.71K	11.21K	12.64K
Other Current Liabilities	5.57M	1.29M	1.12M	1.11M	1.8M	1.66M
Total Current Liabilities	6.01M	1.77M	1.41M	3.86M	14.83M	7.31M
Long-Term Debt	33.81K	278.19K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.19M	5.38M	1.71M	1.21M	1.21M	1.23M
Total Long-Term Liabilities	4.72M	6.39M	2.08M	1.48M	1.4M	2.75M
Total Liabilities	10.72M	8.16M	3.49M	5.34M	16.23M	10.06M
Total Debt	57.17K	326.49K	83.93K	4.71K	16.07K	28.71K
Common Stock	267.68K	55.56K	40.78K	437.94K	172.57K	101.31K
Retained Earnings	-143.38M	-108.34M	-100.25M	-93.15M	-91.82M	-78.6M
Comprehensive Income	-282.16K	-802	139.47K	134.33K	127.47K	120.19K
Shareholders Equity	25.76M	7M	6.62M	8.94M	-1.93M	-329.42K
Total Investments	23M	n/a	n/a	n/a	n/a	n/a